CGM-guided Patch Pump vs Basal-Bolus Injection for Steroid-Induced Hyperglycemia in Sudden Sensorineural Hearing Loss: SHIP Trial

NCT07652528 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Sudden Sensorineural Hearing Loss (SSNHL)
Prediabetes / Type 2 Diabetes

Interventions

DEVICE: CareLevo Patch-type Insulin Pump
DRUG: Insulin Glargine U-100 (Lantus)
DRUG: Fast-acting Insulin Aspart (Fiasp)
DEVICE: CareSens Air Continuous Glucose Monitor

Sponsor

Hallym University